Gradoth
Bullish
now
$PROG Preecludia $3 Billion-market got validated and patented. It’s good to go, no need for FDA approval. Waiting for TOP tier journal publication then embargo lift then HUGE partnership launch for $3B market. Data most likely being published in AJOG journal. They just signed a 3rd Very LARGE pharma partnership with OBDS. Can’t disclose the BIG pharma name yet. Partnership Conference October 28th-29th AVERO advancing to being SOLD this year. Brought in revenue of 35m-40m. Looking to be sold for 100m+ CEO left PROG. Still remains top holder with 12% shares. Athyrium owns 47% CVI owns 9.9% of PROG. Possible buyout/merger as this is a 250B pipeline. $8-10 price target
5
1
12
12 Likes